CFDE Data Portal | Search MIR5091

	Label	Description
	MIR5091 associations Collection (Entity type)	Associations for MIR5091_associations
	MIR5091 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	MIR5091 Gene (Entity type)	ENSG00000266240 - microRNA 5091
	GSE146358 dopamine 3 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 3 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228106 paclitaxel R1192 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE150055 melphalan cardiac muscle cell 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 doxorubicin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 10 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS

MIR5091 associations

Associations for MIR5091_associations

MIR5091 associations.tsv

A file from IDG as part of the Harmonizome project

MIR5091

ENSG00000266240 - microRNA 5091

GSE146358 dopamine 3 v 7 human dn

A Gene Set from LINCS

GSE195663 cisplatin 0 v 1 human up

A Gene Set from LINCS

GSE252944 AKT inhibition 3 v 9 human dn

A Gene Set from LINCS

GSE228106 paclitaxel R1192 0 v 4 human up

A Gene Set from LINCS

GSE150055 melphalan cardiac muscle cell 0 v 2 human up

A Gene Set from LINCS

GSE181517 doxorubicin 0 v 1 human up

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 10 v 4 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.